Male reproduction

ea0026p136 | Male reproduction

Experience with a 1% testosterone gel in treatment of aging males with hypogonadism and type 2 diabetes mellitus

ea0026p137 | Male reproduction

Hypogonadism, insulin resistance and visceral adiposity in myotonic dystrophy

ea0026p138 | Male reproduction

Perceived ejaculate volume reduction in subjects with erectile dysfunction: psycho-biological correlates

ea0026p139 | Male reproduction

Perceived reduced sleep-related erections in subjects with erectile dysfunction: psycho-biological correlates

ea0026p140 | Male reproduction

Sexual interests and hypogonadism in Prader–Willi syndrome (PWS)

ea0026p141 | Male reproduction

Erectile dysfunction does not mirror endothelial dysfunction in hiv-infected patients

ea0026p142 | Male reproduction

P450 aromatase over-expressing mice (AROM+) as a model for infertility in men

ea0026p143 | Male reproduction

The obstructive azoospermia and TESA–ICSI

ea0026p144 | Male reproduction

Does local testosterone therapy in adult men measure up to the 2006 Endocrine Society’s Guidelines?

ea0026p145 | Male reproduction

Criptorchidism, varicocele, azoospermia and Leydig cell tumor in a couple of identical twins with a unique de novo balanced reciprocal translocation.

ea0026p146 | Male reproduction

Transcriptional regulation of germ cell differentiation.

ea0026p147 | Male reproduction

Efficacy of recombinant human follicle-stimulating hormone (rhFSH) in the treatment of male-factor infertility.

ea0026p148 | Male reproduction

Testosterone changes over time in men with human immunodeficiency virus infection: preliminary results

ea0026p149 | Male reproduction

Intramuscular testosterone undecanoate for substitution in male hypogonadism – the experience of 13.5 years

ea0026p150 | Male reproduction

Testosterone administration to hypogonadal men for a period of up to 42 months improves features of the metabolic syndrome

ea0026p151 | Male reproduction

Safety of 42 months of treatment with of long-acting parenteral testosterone undecanoate in men with late-onset hypogonadism

ea0026p152 | Male reproduction

Expression of ghrelin receptor GHSR-1a in mammalian spermatozoa and their response to ghrelin in vitro

ea0026p153 | Male reproduction

Lower serum testosterone and estradiol (E₂) in adult men with unfused epiphyses due to unrecognized and untreated congenital hypogonadotropic hypogonadism: evidence for an E₂ threshold for bone maturation in men

ea0026p154 | Male reproduction

Endocrine Abstracts

13th European Congress of Endocrinology

Poster Presentations

Experience with a 1% testosterone gel in treatment of aging males with hypogonadism and type 2 diabetes mellitus

Hypogonadism, insulin resistance and visceral adiposity in myotonic dystrophy

Perceived ejaculate volume reduction in subjects with erectile dysfunction: psycho-biological correlates

Perceived reduced sleep-related erections in subjects with erectile dysfunction: psycho-biological correlates

Sexual interests and hypogonadism in Prader–Willi syndrome (PWS)

Erectile dysfunction does not mirror endothelial dysfunction in hiv-infected patients

P450 aromatase over-expressing mice (AROM+) as a model for infertility in men

The obstructive azoospermia and TESA–ICSI

Does local testosterone therapy in adult men measure up to the 2006 Endocrine Society’s Guidelines?

Criptorchidism, varicocele, azoospermia and Leydig cell tumor in a couple of identical twins with a unique de novo balanced reciprocal translocation.

Transcriptional regulation of germ cell differentiation.

Efficacy of recombinant human follicle-stimulating hormone (rhFSH) in the treatment of male-factor infertility.

Testosterone changes over time in men with human immunodeficiency virus infection: preliminary results

Intramuscular testosterone undecanoate for substitution in male hypogonadism – the experience of 13.5 years

Testosterone administration to hypogonadal men for a period of up to 42 months improves features of the metabolic syndrome

Safety of 42 months of treatment with of long-acting parenteral testosterone undecanoate in men with late-onset hypogonadism

Expression of ghrelin receptor GHSR-1a in mammalian spermatozoa and their response to ghrelin in vitro

Lower serum testosterone and estradiol (E₂) in adult men with unfused epiphyses due to unrecognized and untreated congenital hypogonadotropic hypogonadism: evidence for an E₂ threshold for bone maturation in men

Erectile dysfunction in endocrine patients (pituitary diseases)

BiosciAbstracts